Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor G Safonov

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Organic Letters|February 15, 2002
Total synthesis of (+)-dactylolideAmos B Smith, Igor G Safonov
Journal of the American Chemical Society|September 13, 2002
Total syntheses of (+)-zampanolide and (+)-dactylolide exploiting a unified strategyAmos B Smith, Igor G Safonov, R Michael Corbett
Bioorganic & Medicinal Chemistry Letters|December 27, 2005
New benzimidazoles as thrombopoietin receptor agonistsIgor G Safonov, Dirk A Heerding, Richard M Keenan, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridinesHong Lin, Dennis S Yamashita, Ren Xie, et al.
Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Organic Letters|February 15, 2002
Total synthesis of (+)-dactylolideAmos B Smith, Igor G Safonov
Journal of the American Chemical Society|September 13, 2002
Total syntheses of (+)-zampanolide and (+)-dactylolide exploiting a unified strategyAmos B Smith, Igor G Safonov, R Michael Corbett
Bioorganic & Medicinal Chemistry Letters|December 27, 2005
New benzimidazoles as thrombopoietin receptor agonistsIgor G Safonov, Dirk A Heerding, Richard M Keenan, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridinesHong Lin, Dennis S Yamashita, Ren Xie, et al.
Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.
Pageof 1